A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] administration
age
antiviral therapy
approved
asked
assumption
blind
blinded
carried
Chemical
Chemotherapy
clinical
clinical trial
COVID
COVID-19
COVID-19 patient
COVID-19 positive patients
Cytokine analysis
cytokine profile
determine
dissemination
edentulous
Effectiveness
element
eligibility assessment
excluded
expected
explained
female
FIVE
Flow
gargles
Glasgow coma score
group
hospitalised
hydrogen
hypertonic
identify
IFN-γ
IL-10
IL-2
IL-4
IL-6
Immunological test
Inc.
inclusion criteria
Intervention
Intubated
Karachi
Laboratory
laboratory-confirmed
lesion
male
Mild
moderate disease
mucosal
nasal
Nasal lavage
number
objective
outcome
parallel group
participant
Patient
PCR test
positive controls
Primary outcome
product
protocol
provided
Purposive sampling
quantitative PCR
Radiotherapy
randomised
randomised controlled trial
real time
reducing
reduction in
Registered
reported
Research
Research question
salivary
Sample size
sealed
Standard
status
study group
Study protocol
subject
Symptoms
the patient
TNF-α
treated
Trial
unit
university
university hospital
Viral load
website
[DOI] 10.1186/s13063-020-04634-2 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04634-2 PMC 바로가기 [Article Type] Letter